Research (Jiang et al., 2011) suggested that downregulation of S100B expression in non-small cell lung cancer (NSCLC) could significantly inhibit cell cycle progression, reduce colony formation, cell migration, and invasion activities, leading to decreased cell proliferation. This evidence concerns the gene S100B and non-small cell lung carcinoma.